title: Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome.
authors.affiliation: Department of Diabetes and Endocrinology, University of Hull, Hull, UK.
authors.forename: Thozhukat
authors.initials: T
authors.lastname: Sathyapalan
authors.affiliation: Weill Cornell Medicine Qatar, Doha, Qatar. yhd2001@qatar-med.cornell.edu.
authors.forename: Youssra
authors.identifier: 0000-0002-2839-6831
authors.initials: Y
authors.lastname: Dakroury
authors.affiliation: Weill Cornell Medicine Qatar, Doha, Qatar.
authors.forename: Lina
authors.initials: L
authors.lastname: Ahmed
authors.affiliation: Weill Cornell Medicine Qatar, Doha, Qatar.
authors.forename: Abeer M M
authors.initials: AM
authors.lastname: Elshewehy
authors.affiliation: Sidra Research Centre, Doha, Qatar.
authors.forename: Eric S
authors.initials: ES
authors.lastname: Kilpatrick
authors.affiliation: Department of Obstetric Ultrasound, Hull & East Yorkshire Women's & Children's Hospital, Hull, UK.
authors.forename: Anne-Marie
authors.initials: AM
authors.lastname: Coady
authors.affiliation: Weill Cornell Medicine Qatar, Doha, Qatar.
authors.forename: Stephen L
authors.identifier: 0000-0002-5887-7257
authors.initials: SL
authors.lastname: Atkin
mesh_terms: D015992:Body Mass Index; D063387:Cannabinoid Receptor Antagonists / Q000627:therapeutic use*; D016207:Cytokines / Q000097:blood; D005260:Female; D017228:Hepatocyte Growth Factor / Q000097:blood*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use; D007333:Insulin Resistance; D008687:Metformin / Q000627:therapeutic use; D065626:Non-alcoholic Fatty Liver Disease / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D009765:Obesity / Q000097:blood / Q000150:complications; D010880:Piperidines / Q000627:therapeutic use*; D011085:Polycystic Ovary Syndrome / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D011720:Pyrazoles / Q000627:therapeutic use*; D000077285:Rimonabant
chemical_list: D063387:Cannabinoid Receptor Antagonists; D016207:Cytokines; D007004:Hypoglycemic Agents; D007328:Insulin; D010880:Piperidines; D011720:Pyrazoles; D017228:Hepatocyte Growth Factor; D008687:Metformin; D000077285:Rimonabant